Essential and Orphan Drugs in Panama: Perception of Competition and Implications of Pricing Policy

Víctor H. Herrera Ballesteros (victor.herrerab@up.ac.pa), Ilais Moreno Velásquez, Eric I. Conte, Cecilio N. Hall and Beatriz Gómez

Revista de Economía del Rosario, 2020, vol. 23, issue 2, No 18220, 115-134

Abstract: We measured the perception of competition in the market for essential and orphan drugs. The inflation rate for original products was 0.002 annually, whereas that for generic drugs was 0.005. The province of Panama, containing 46.5 % of private pharmacies, has the lowest index in the perception of competition; 18 % of the respondents to the out-ofpocket expenditure survey did not have drugs available, and 55 % could not afford them. The Gini coefficients were 0.40 (2014) and 0.76 (2017). The increase in prices, the relative independence of retailers to establish prices, and low access to social/private insurance increase the out-of-pocket expenses

Keywords: Economic competition; generic drug policy; orphan drug; pharmacy; therapeuticequivalency (search for similar items in EconPapers)
JEL-codes: H5 H51 H53 H55 (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://revistas.urosario.edu.co/index.php/economia/article/view/9179

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:col:000151:018220

Access Statistics for this article

More articles in Revista de Economía del Rosario from Universidad del Rosario Contact information at EDIRC.
Bibliographic data for series maintained by Facultad de Economía (mariajos.pinzon@urosario.edu.co).